Nantahala Capital Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
SCM
SCM
DCM
PCM
SCM
WA
Nantahala Capital Management's TELA Position: Q2 2026 in Review
Nantahala Capital Management increased its TELA Bio (TELA) stake by 15% in Q2 2026, buying an estimated $614K and bringing the position to 5,894,114 shares worth $4.42M. The position accounts for 0.15% of the portfolio, ranked #112.
Nantahala Capital Management first reported a position in TELA in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.5M in Q2 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.
- Nantahala Capital Management held 5,894,114 shares of TELA Bio worth $4.42M as of Q2 2026.
- Nantahala Capital Management bought 750,000 TELA Bio shares in Q2 2026, an estimated $614K.
- TELA Bio made up 0.15% of Nantahala Capital Management's portfolio in Q2 2026, its #112 holding.
- Nantahala Capital Management first reported a position in TELA Bio in Q3 2022 and has held it in 16 quarters since.
- Nantahala Capital Management's TELA Bio position peaked at $11.5M in Q2 2024.
- 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.
Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.